Sen. Bernie Sanders (I-Vermont) has condemned the Biden administration’s decision this week to reject a request to lower the price of an extremely expensive prostate cancer drug that can help extend the lives of patients for months or years. Failing what advocates considered a litmus test of the administration’s willingness to act on prescription drug prices on Tuesday, the National Institutes of… Source Source / Read More: Sanders Slams Biden for Rejecting Request to Lower Price of $190K Cancer Drug
Cancer
Venezuela: UN backs Venezuelan victims’ and civil society’s fight for truth and justice
During its 51st session, the UN Human Rights Council passed a resolution renewing the mandate of the International Independent Fact-Finding Mission on Venezuela, created by the same body in September 2019, for two more years. In response, Erika Guevara-Rosas, Americas director at Amnesty International, stated: “Amnesty International welcomes the renewal of the Fact-Finding Mission on […] The post Venezuela: UN backs Venezuelan victims’ and civil society’s fight for truth and justice appeared first on Amnesty International.
Abortion Bans Could Jeopardize Cancer Treatment for Pregnant Patients
As abortion bans go into effect across a contiguous swath of the South, cancer physicians are wrestling with how new state laws will influence their discussions with pregnant patients about what treatment options they can offer. Cancer coincides with roughly 1 in 1,000 pregnancies, most frequently breast cancer, melanoma, cervical cancer, lymphomas, and leukemias. But medications and other treatments can be toxic to the developing fetus or cause birth defects. In some cases, hormones that are supercharged during pregnancy fuel the cancer’s growth, putting the patient at greater risk. Although new abortion restrictions often allow exceptions based on “medical emergency”…
Appeals Court Rules Lawsuit Linking Roundup to Cancer Diagnosis Can Move Forward
A federal appeals court has revived a lawsuit brought forward by a Georgia man who says decades of use of Roundup, a weed-killing product produced by parent company Bayer AG, led to his cancer diagnosis in 2016. Bayer AG purchased Roundup, a controversial product many believe is linked to other cancer diagnoses in the U.S., from Monsanto in 2018. John Carson, a Georgia resident who had used Roundup for 30 years, said the product led to his being diagnosed with malignant fibrous histiocytoma. He alleges the company should have included a label explaining the risk for cancer on the packaging.…